Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS, activism, and ethics.

D J Rothman1, H Edgar

  • 1Center for the Study of Society Medicine, Columbia University College of Physicians and Surgeons.

Hospital Practice (Office Ed.)
|July 15, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracting root fragments.

British dental journal·2024
Same author

Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts.

Veterinary parasitology·2008
Same author

Reflectometer for measuring the bidirectional reflectance of rough surfaces.

Applied optics·2008
Same author

The hidden cost of organ sale.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

Body shop.

The Sciences·2005
Same author

The shame of medical research.

The New York review of books·2002
Same journal

Oral contraceptives: an update.

Hospital practice (Office ed.)·1995
Same journal

Progress in the immunogenetics of rheumatoid arthritis.

Hospital practice (Office ed.)·1995
Same journal

An asymptomatic lung nodule in an elderly woman with joint pain.

Hospital practice (Office ed.)·1995
Same journal

Defusing status epilepticus.

Hospital practice (Office ed.)·1995
Same journal

Persistent fever and flank discomfort in a young woman.

Hospital practice (Office ed.)·1995
Same journal

New thoughts on attention-deficit/hyperactivity disorder.

Hospital practice (Office ed.)·1995
See all related articles

AIDS advocates have empowered patients and physicians by shifting drug approval decisions away from government and researchers. This analysis explores the ethical and clinical impacts of increased patient autonomy in treatment access.

Area of Science:

  • Public Health
  • Health Policy
  • Bioethics

Background:

  • Historically, regulatory bodies and researchers held primary control over drug approval processes.
  • AIDS advocacy groups have been instrumental in challenging traditional pharmaceutical access models.
  • Previous FDA critics faced limitations in decentralizing decision-making power.

Purpose of the Study:

  • To analyze the impact of AIDS advocacy on patient and physician involvement in drug access decisions.
  • To discuss the ethical and clinical consequences of shifting decision-making power.
  • To examine the evolution of drug approval pathways influenced by patient advocacy.

Main Methods:

  • Review of historical advocacy efforts and policy changes (e.g., treatment IND, parallel track).
Keywords:
Biomedical and Behavioral ResearchHealth Care and Public Health

Related Experiment Videos

  • Analysis of ethical frameworks related to patient autonomy and informed consent.
  • Discussion of clinical implications for treatment accessibility and physician-patient relationships.

    • Main Results:

    • AIDS advocates successfully transferred significant decision-making authority from regulatory bodies to patients and physicians.
    • New pathways like treatment IND, drug importation, and parallel track expanded access.
    • Patient-centered approaches have become more prominent in pharmaceutical policy.

    Conclusions:

    • Patient advocacy has fundamentally altered the landscape of drug access and regulatory control.
    • The shift in decision-making power carries significant ethical and clinical implications requiring ongoing evaluation.
    • Future drug policy may increasingly incorporate patient and physician input.